Clinova Pathlabs Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 05-11-2024
- Paid Up Capital ₹ 1.85 Cr
as on 05-11-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -34.38%
(FY 2023)
- Profit -348.43%
(FY 2023)
- Ebitda -234.03%
(FY 2023)
- Net Worth -114.42%
(FY 2023)
- Total Assets -23.85%
(FY 2023)
About Clinova Pathlabs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kumaraswamy Yedavally, Ramakrishna Dega, Miriyala Babu, and Six other members serve as directors at the Company.
- CIN/LLPIN
U85300TG2020PTC139321
- Company No.
139321
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2020
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Clinova Pathlabs?
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumaraswamy Yedavally  | Director | 15-Mar-2021 | Current |
| Ramakrishna Dega | Director | 03-Jun-2020 | Current |
| Miriyala Babu | Director | 03-Jun-2020 | Current |
| Rathore Singh | Director | 22-Dec-2020 | Current |
| Bhagatsingh Chinta | Director | 15-Mar-2021 | Current |
| Manish Kumar | Director | 15-Mar-2021 | Current |
Financial Performance of Clinova Pathlabs.
Clinova Pathlabs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.38% decrease. The company also saw a substantial fall in profitability, with a 348.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 114.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinova Pathlabs?
In 2023, Clinova Pathlabs had a public holding of 99.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clinova Pathlabs?
Clinova Pathlabs has a workforce of 156 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinova Pathlabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinova Pathlabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
